Anticoagulation in Liver Fibrosis in Patients With Hepatitis C Virus Infection

NCT00180674 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Liver Fibrosis

Interventions

DRUG: Warfarin

Sponsor

Imperial College London